Insider buying · SEC Form 4

Insider Buying — Oct 23, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

4insider buys
$15.9Mbought in total
4companies
0by CEOs, CFOs and other chiefs
DOLElargest: $8.55M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
DOLEDole plcPale Fire Capital SE (Dusan Senkypl)10% Owner$8.55M648,356$13.19AddedOct 22, 2026
Form 4 ↗
Multi-day accumulation Oct 20–22: 45,676 shares at $13.24, 438,900 shares at $13.12, 163,780 shares at $13.39. Weighted avg ~$13.19. Czech value/activist fund adding aggressively. Current price $13.52, +2.5% vs avg buy.
CRBGCorebridge Financial IncNippon Life Insurance Co10% Owner$6.77M193,357$35.01AddedOct 22, 2026
Form 4 ↗
Purchased Oct 20 at $35.01 weighted avg (range $34.51–$35.34). Rule 10b5-1 plan adopted Aug 7, 2026 — scheduled, non-discretionary buy. Nippon Life holds 130M+ shares post-transaction. Current price $35.59, +1.7% vs buy.
MXFMexico Equity & Income Fund IncSaba Capital Management LP (Boaz Weinstein)10% Owner$327K16,035$20.42AddedOct 22, 2026
Form 4 ↗
Purchased Oct 21 at $20.42. Saba CEF activism cluster — 5 Form 4s filed Oct 22 across various closed-end funds. MXF trades at discount to NAV; Saba likely seeking tender offer or board representation. Current price $20.18, -1.2% vs buy.
LEOBNY Mellon Strategic Municipals IncSaba Capital Management LP (Boaz Weinstein)10% Owner$263K45,831$5.73AddedOct 22, 2026
Form 4 ↗
Purchased Oct 21 at $5.73. Part of Saba Capital's same-day CEF discount activism cluster. LEO is a muni bond CEF; Saba holds 6.48M shares post-transaction. Current price $5.70, -0.5% vs buy.

AIThe day in insider buying

SEC Form 4 Insider Scan — October 23, 2026

Scanned the last 24 hours of EDGAR Form 4 filings (Oct 22–23, 2026). 4 qualifying buys (≥ $250K, transaction type P) totalling $15.9M.

Headline Filings

  • DOLE — Pale Fire Capital SE / Dusan Senkypl (10% Owner) bought 648,356 shares ≈ $8.55M at $13.19 avg over 3 consecutive days (Oct 20–22); now $13.52 (+2.5% since buy). Czech activist/value fund aggressively accumulating Dole plc. (filing)
  • CRBG — Nippon Life Insurance Co (10% Owner) bought 193,357 shares ≈ $6.77M at $35.01 avg (Oct 20); now $35.59 (+1.7% since buy). Largest Japanese life insurer continuing its systematic accumulation under a Rule 10b5-1 plan adopted Aug 7, 2026. (filing)
  • MXF — Saba Capital Management LP / Boaz Weinstein (10% Owner) bought 16,035 shares ≈ $327K at $20.42 (Oct 21); now $20.18 (−1.2% since buy). (filing)
  • LEO — Saba Capital Management LP / Boaz Weinstein (10% Owner) bought 45,831 shares ≈ $263K at $5.73 (Oct 21); now $5.70 (−0.5% since buy). (filing)

Notes

Themes: Today's qualifying activity was dominated by large institutional 10%+ owners rather than classic C-suite insiders. No CEO/CFO/Director open-market purchases crossed the $250K threshold, which is notable. The session breaks into two clusters:

  1. Cross-border accumulation: Pale Fire Capital (Prague-based; led by Dusan Senkypl, who also chairs the firm's SICAV) bought nearly 650K shares of DOLE across three sessions, spending ~$8.55M. The multi-day cadence and weighted-average prices ($13.12–$13.39) suggest a deliberate accumulation campaign, not a one-off trade. Dole plc is a value-play at ~5× EV/EBITDA. Nippon Life's CRBG add is a continuation of a 10b5-1 program; Nippon has been a cornerstone shareholder since Corebridge's 2022 AIG spin-off.
  1. CEF discount activism (Saba Capital): Boaz Weinstein's Saba Capital filed 5 Form 4s on Oct 22 for various closed-end funds—only MXF ($327K) and LEO ($263K) cleared the $250K bar. The other three (DSM at $109K, GF at $26K, ECF at $30K) were sub-threshold. Saba's strategy: buy CEFs trading at significant NAV discounts and push for open-ending, tender offers, or board seats. Both MXF and LEO trade at persistent discounts to NAV.

Notable near-miss: John Maraganore (Director, Rapport Therapeutics / RAPP) bought 9,411 shares at $26.45 avg = ~$249K on Oct 22 — just below the $250K threshold. Multiple RAPP directors bought the same day, suggesting cluster conviction following RAPP's recent clinical data; total cluster value was ~$450K across 4 filers.

Most-bought stocks, last 30 days

  • LEN $193M · 1 buyLennar Corporation
  • CRBG $97.6M · 7 buys, 2 insidersCorebridge Financial Inc
  • BORR $51.3M · 8 buysBorr Drilling Ltd
  • GME $50.7M · 4 buys, 2 insidersGameStop Corp.
  • GPI $39.9M · 2 buysGroup 1 Automotive Inc.
  • ADRX $37.3M · 2 buys, 2 insidersADARx Pharmaceuticals, Inc.
  • BPRE $22.2M · 4 buysBluerock Private Real Estate Fund
  • QVCG $16.7M · 1 buyQVC Group, Inc.
  • AVR $16.6M · 4 buysAnteris Technologies Global Corp.
  • IAM $11.5M · 1 buyIambic Therapeutics, Inc.
  • COUR $11.4M · 1 buyCoursera, Inc.
  • PSUS $9.61M · 1 buyPershing Square USA, Ltd.
  • NYAX $9.22M · 2 buysNayax Ltd.
  • DOLE $8.55M · 1 buyDole plc
  • APLD $6.66M · 2 buys, 2 insidersApplied Digital Corp.
  • GPUS $5.00M · 1 buyHyperscale Data, Inc.
  • GOLD $3.94M · 2 buys, 2 insidersGold.com, Inc.
  • ACCV $3.66M · 1 buyAccelevation Holdings Corp.
  • FLSC $3.00M · 1 buyFrazier Life Sciences Acquisition Corp. II
  • KBDC $2.87M · 2 buysKayne Anderson BDC Inc

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.